XL-281
XL-281 (BMS-908662) is an orally active inhibitor for RAF kinase, with IC50s of 2.6, 4.5 and 6 nM, for CRAF, B-RAF, and B-RAFV600E, respectively. XL-281 exhibits antitumor activity.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 870603-16-0
- Fòrmula: C24H19ClN4O4
- Peso molecular:462.89
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
|
C-Raf 2.6 nM (IC50) |
B-Raf 4.5 nM (IC50) |
B-RafV600E 6 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SK-MEL19 | IC50 |
200 nM
Compound: 8; XL281; BMS-908662
|
Cytotoxicity against human SK-MEL-19 cells harboring BRAF mutant after 3 days
Cytotoxicity against human SK-MEL-19 cells harboring BRAF mutant after 3 days
|
[PMID: 29461827] |
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 870603-16-0
-
Peso molecular 462.89
-
Fòrmula C24H19ClN4O4
-
SMILES
O=C(OC)NC1=NC2=CC=C(C3(O)N(C4=CC(Cl)=CC=C4C)C(C5=C3C=CC=C5)=O)C=C2N1
-
Synonyms
BMS-908662
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)